BioMark Diagnostics Inc. (BUX.CN)

CAD 0.2

(0.0%)

Long Term Debt Summary of BioMark Diagnostics Inc.

BioMark Diagnostics Inc.'s latest annual long term debt in 2023 was 454.15 Thousand CAD , up 108.89% from previous year.
BioMark Diagnostics Inc.'s latest quarterly long term debt in 2024 Q1 was 399.98 Thousand CAD , down 0.0% from previous quarter.
BioMark Diagnostics Inc. reported annual long term debt of 217.41 Thousand CAD in 2022, down -64.12% from previous year.
BioMark Diagnostics Inc. reported annual long term debt of 606.03 Thousand CAD in 2021, up 452.87% from previous year.
BioMark Diagnostics Inc. reported quarterly long term debt of 454.15 Thousand CAD for 2023 Q4, down -16.9% from previous quarter.
BioMark Diagnostics Inc. reported quarterly long term debt of 182.36 Thousand CAD for 2023 Q1, down -16.12% from previous quarter.

Annual Long Term Debt Chart of BioMark Diagnostics Inc. (2023 - 2013)

Historical Annual Long Term Debt of BioMark Diagnostics Inc. (2023 - 2013)

Year	Long Term Debt	Long Term Debt Growth
2023	454.15 Thousand CAD	108.89%
2022	217.41 Thousand CAD	-64.12%
2021	606.03 Thousand CAD	452.87%
2020	109.61 Thousand CAD	0.0%
2019	- CAD	0.0%
2018	- CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%
2015	- CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	399.98 Thousand CAD	0.0%
2023 Q4	454.15 Thousand CAD	-16.9%
2023 Q1	182.36 Thousand CAD	-16.12%
2023 FY	454.15 Thousand CAD	108.89%
2023 Q2	145.95 Thousand CAD	-19.96%
2023 Q3	546.51 Thousand CAD	274.43%
2022 Q4	217.41 Thousand CAD	-37.22%
2022 Q3	346.28 Thousand CAD	-17.65%
2022 Q2	420.48 Thousand CAD	-17.32%
2022 Q1	508.59 Thousand CAD	-16.08%
2022 FY	217.41 Thousand CAD	-64.12%
2021 Q1	108.01 Thousand CAD	-1.46%
2021 Q2	106.4 Thousand CAD	-1.49%
2021 FY	606.03 Thousand CAD	452.87%
2021 Q3	678.61 Thousand CAD	537.75%
2021 Q4	606.03 Thousand CAD	-10.7%
2020 Q3	100 Thousand CAD	25.0%
2020 Q4	109.61 Thousand CAD	9.62%
2020 Q1	- CAD	0.0%
2020 Q2	80 Thousand CAD	0.0%
2020 FY	109.61 Thousand CAD	0.0%
2019 Q2	- CAD	0.0%
2019 Q1	- CAD	0.0%
2019 FY	- CAD	0.0%
2019 Q4	- CAD	0.0%
2019 Q3	- CAD	0.0%
2018 Q3	- CAD	0.0%
2018 Q4	- CAD	0.0%
2018 FY	- CAD	0.0%
2018 Q1	- CAD	0.0%
2018 Q2	- CAD	0.0%
2017 FY	- CAD	0.0%
2017 Q4	- CAD	0.0%
2017 Q3	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 Q1	- CAD	0.0%
2016 Q1	- CAD	0.0%
2016 FY	- CAD	0.0%
2016 Q2	- CAD	0.0%
2016 Q4	- CAD	0.0%
2016 Q3	- CAD	0.0%
2015 Q1	- CAD	0.0%
2015 Q3	- CAD	0.0%
2015 Q4	- CAD	0.0%
2015 FY	- CAD	0.0%
2015 Q2	- CAD	0.0%
2014 FY	- CAD	0.0%
2014 Q2	- CAD	0.0%
2014 Q3	- CAD	0.0%
2014 Q4	- CAD	0.0%
2014 Q1	- CAD	0.0%
2013 FY	- CAD	0.0%

Peer Long Term Debt Comparison of BioMark Diagnostics Inc.

Name	Long Term Debt	Long Term Debt Difference
Izotropic Corporation	15.3 Thousand CAD	-2868.34%
Sona Nanotech Inc.	527.68 Thousand CAD	13.934%